Effects of Telbivudine Treatment on the Circulating CD4⁺ T-Cell Subpopulations in Chronic Hepatitis B Patients

Figure 2

Changes in mRNA expressions of critical transcriptional factors for CD4⁺ T-cell subpopulations in response to telbivudine treatment. PBMCs from the healthy controls and CHB patients treated with telbivudine were used to detect the relative mRNA expression levels of the CD4⁺ T-cell subtype-specific transcription factors by qPCR. *𝑃<0.05, **𝑃<0.01, and ***𝑃<0.001  versus the respective baseline or 52-week value. Ns: no significance.

(a)

(b)

(c)

(d)